Webster Equity's Bristol Hospice preps sale process

The upcoming process for Bristol comes as Webster runs a secondaries process for two existing Fund III portfolio companies: BayMark and Pharmalogic.

19 January 2021•2 mins read
Webster Capital, Bristol Hospice, healthcare, private equity, merger, M&A
LinkedInXEmail
LinkedInXEmail

Related articles